Showing 651-660 of 19240 results for "".
Health Care: Public Policy vs. Insiders Views
https://reachmd.com/programs/clinicians-roundtable/health-care-public-policy-vs-insiders-views/1088/Physicians ask, “What do I need to do right now for this specific patient today to maintain health.” Public Policy advocates ask, “What do we need to do in the future to ensure the health of our society.” How do we reconcile these different viewpoints to become a healthier nation?Keys to Closing the Gender Gap in Stroke Trials
https://reachmd.com/programs/neurofrontiers/keys-to-closing-the-gender-gap-in-stroke-trials/13461/Why are women underrepresented in stroke trials, and what can be done to reverse this troubling trend?Interchangeability and Biologics, Biosimilars, and Generics
https://reachmd.com/programs/clinicians-roundtable/interchangeability-and-biologics-biosimilars-and-generics/15987/With the ever-changing landscape of treatments, there are biosimilars for diabetes, inflammatory conditions, and cancers. Read more.PCOS: The Challenge of Diagnosis and Medical Risk
https://reachmd.com/programs/advances-in-womens-health/pcos-the-challenge-of-diagnosis-and-medical-risk/1878/Polycystic ovary syndrome (PCOS) imperils reproductive age women, posing pressing concerns about fertility, and increasing risk of diabetes, heart disease, and endometrial cancer. Dr. Sam Thatcher, director of the multi-site Center for Applied Reproductive Science, considers the mechanisms of PCOS iAn Overview of Current Management Limitations
https://reachmd.com/programs/cme/An-Overview-of-Current-Management-Limitations/35968/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.New Therapies: The Basics
https://reachmd.com/programs/cme/New-Therapies-The-Basics/35970/Catch up on the latest information on the management of macular telangiectasia type 2 (MacTel) with a new encapsulated cell therapy, revakinagene taroretcel.Patient at High Risk of Loss to Follow-Up, Part of the Focused Sight Initiative: Quality Improvement Interventions in Retinal Disease
https://reachmd.com/programs/cme/patient-at-high-risk-of-loss-to-follow-up-part-of-the-focused-sight-initiative-quality-improvement-interventions-in-retinal-disease/37711/Explore a case of severe diabetic macular edema and strategies for engaging busy, working-age patients in ongoing anti-VEGF therapy and follow-up care.Improving Survival and Function in Pediatric TK2d with Nucleoside Therapy
https://reachmd.com/programs/clinicians-roundtable/improving-survival-and-function-in-pediatric-tk2d/37635/What if a rare, progressive neuromuscular disease like thymidine kinase 2 deficiency (TK2d) could not only be stabilized, but partially reversed? Based on findings from a pooled analysis of pediatric patients, pyrimidine nucleoside or nucleotide therapy reduced mortality risk up to 95%, with nearlyAnti-inflammatory, Anti-atherogenic and Cardioprotective Effects of Insulin
https://reachmd.com/programs/diabetes-discourse/anti-inflammatory-anti-atherogenic-and-cardioprotective-effects-of-insulin/6691/Host Dr. Farhad Zangeneh welcomes Paresh Dandona MD, PhD, Professor and Chief of Endocrinology in the Department of Medicine at the University of Buffalo. His Specialty and Research Focus are in Endocrinology, Diabetes and Metabolism. He is also the Founder & Medical Director of the Diabetes-EnBuilding Bone Vitality Without Dairy, Calcium, Estrogen, or Drugs: Is It Nutritionally Possible?
https://reachmd.com/programs/nutritionedge/building-bone-vitality-without-dairy-calcium-estrogen-drugs-nutritionally-possible/8461/Dr. Amy Lanou talks about a different nutritional approach to preventing bone loss and reversing osteoporosis.